Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XCSEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.7.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GA.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.15.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.15.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.40EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CR.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KB.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
KB.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HU.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JB.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JB.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.55EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HH.8.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HH.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.19EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FM.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
FM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAJEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XAJEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.431EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.431EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.168EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.168EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.6 (Alpha)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Q.6 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.97EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.97EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.4.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BM.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.20EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.77EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CP.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FC.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
FC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BY.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BY.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.272EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.272EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.371EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used